These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Neonatal toxicity of naphazoline administrated during pregnancy]. Dageville C; Joly E; Spreux A; Berard E Therapie; 1995; 50(5):472-3. PubMed ID: 8571292 [No Abstract] [Full Text] [Related]
3. False-negative apraclonidine testing in acute Horner syndrome. Dewan MA; Harrison AR; Lee MS Can J Ophthalmol; 2009 Feb; 44(1):109-10. PubMed ID: 19169332 [No Abstract] [Full Text] [Related]
4. [Decongestants in treatment of nasal obstruction]. Bogacka E Otolaryngol Pol; 1999; 53(3):347-52. PubMed ID: 10481510 [TBL] [Abstract][Full Text] [Related]
5. Horner's syndrome in an eastern screech owl (Megascops asio). Gancz AY; Lee S; Higginson G; Danylyk I; Smith DA; Taylor M Vet Rec; 2006 Sep; 159(10):320-2. PubMed ID: 16950890 [No Abstract] [Full Text] [Related]
6. Possible effect of systemic sympathicolytic drugs on apraclonidine test. Martín-Moro JG; Botín DM; Muñoz-Negrete FJ Can J Ophthalmol; 2009 Aug; 44(4):463; author reply 463-4. PubMed ID: 19606173 [No Abstract] [Full Text] [Related]
7. Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants. Watts P; Satterfield D; Lim MK J AAPOS; 2007 Jun; 11(3):282-3. PubMed ID: 17572343 [TBL] [Abstract][Full Text] [Related]
8. Cluster Syncope. Manne JR Am J Med; 2016 Feb; 129(2):e13-4. PubMed ID: 26524707 [No Abstract] [Full Text] [Related]
9. Treatment of allergic conjunctivitis with ocular decongestants. Smith JP; Lanier BQ; Tremblay N; Ward RL; deFaller JM Curr Eye Res; 1982-1983; 2(2):141-7. PubMed ID: 6129113 [No Abstract] [Full Text] [Related]
10. Tolerance and absence of rebound vasodilation following topical ocular decongestant usage. Abelson MB; Butrus SI; Weston JH; Rosner B Ophthalmology; 1984 Nov; 91(11):1364-7. PubMed ID: 6514304 [TBL] [Abstract][Full Text] [Related]
11. [Treatment results with dioxopromethazine nose drops]. Knothe J; Baerthold W; Aschoff E Pharmazie; 1970 Feb; 25(2):121-4. PubMed ID: 4192880 [No Abstract] [Full Text] [Related]
12. [Evaluation of E-221-005 in inflammatory nasal diseases by double blind metod]. Baba S; Oashi M; Onoda T Jibiinkoka; 1972 Feb; 44(2):153-7. PubMed ID: 4111383 [No Abstract] [Full Text] [Related]
14. Benefits, limits and danger of ephedrine and pseudoephedrine as nasal decongestants. Laccourreye O; Werner A; Giroud JP; Couloigner V; Bonfils P; Bondon-Guitton E Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Feb; 132(1):31-4. PubMed ID: 25532441 [TBL] [Abstract][Full Text] [Related]
15. [Chronic rhinitis and its treatment]. Jacobi KH Z Allgemeinmed; 1969 Jul; 45(21):1004-7. PubMed ID: 4187659 [No Abstract] [Full Text] [Related]
16. [Nasal decongestants and eye drops: keep out of children's reach!]. Poulin-Chartrand S Perspect Infirm; 2013; 10(2):63. PubMed ID: 23539872 [No Abstract] [Full Text] [Related]
17. Naphazoline as a confounder in the diagnosis of carotid artery dissection. Pemberton JD; MacIntosh PW; Zeglam A; Fay A Ophthalmic Plast Reconstr Surg; 2015; 31(2):e33-5. PubMed ID: 24807801 [TBL] [Abstract][Full Text] [Related]
18. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome. Brown SM Arch Ophthalmol; 2005 Apr; 123(4):578; author reply 578. PubMed ID: 15824244 [No Abstract] [Full Text] [Related]